Wave Life Sciences Files 8-K
Ticker: WVE · Form: 8-K · Filed: Jun 25, 2024 · CIK: 1631574
| Field | Detail |
|---|---|
| Company | Wave Life Sciences Ltd. (WVE) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
Wave Life Sciences filed an 8-K, standard procedure, check for material updates.
AI Summary
Wave Life Sciences Ltd. filed an 8-K on June 25, 2024, reporting on other events and financial statements. The filing does not contain specific material events or financial figures that would typically be highlighted in a summary.
Why It Matters
This 8-K filing indicates that Wave Life Sciences Ltd. has submitted a regulatory document to the SEC, which may contain updates or disclosures relevant to investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K submission without immediate indication of significant positive or negative events.
Key Players & Entities
- Wave Life Sciences Ltd. (company) — Registrant
- June 25, 2024 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing for Wave Life Sciences Ltd.?
This 8-K filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, filed on June 25, 2024, and includes information on Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
What is the company's jurisdiction of incorporation and fiscal year end?
Wave Life Sciences Ltd. is incorporated in Singapore and its fiscal year ends on December 31.
What are the business and mailing addresses provided in the filing?
The business address is 7 Straits View #12-00, Marina One East Tower, Singapore 018936, and the mailing address is 733 Concord Avenue, Cambridge, MA 02138.
What is the SIC code for Wave Life Sciences Ltd.?
The Standard Industrial Classification (SIC) code for Wave Life Sciences Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Has the company undergone any name changes?
Yes, the company was formerly known as WAVE Life Sciences Ltd. with a date of name change on May 16, 2017, and also as Wave Life Sciences Ltd. with a date of name change on November 6, 2015.
Filing Stats: 655 words · 3 min read · ~2 pages · Grade level 9.7 · Accepted 2024-06-25 07:36:30
Key Financial Figures
- $0 — of each exchange on which registered $0 Par Value Ordinary Shares WVE The N
Filing Documents
- d771392d8k.htm (8-K) — 26KB
- d771392dex991.htm (EX-99.1) — 27KB
- g771392g0625084841720.jpg (GRAPHIC) — 4KB
- 0001193125-24-167481.txt ( ) — 188KB
- wve-20240625.xsd (EX-101.SCH) — 3KB
- wve-20240625_lab.xml (EX-101.LAB) — 18KB
- wve-20240625_pre.xml (EX-101.PRE) — 11KB
- d771392d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d)Exhibits The following exhibit relating to Item 7.01 is furnished and not filed: Exhibit No. Description 99.1 Press Release issued by Wave Life Sciences Ltd. dated June 25, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. WAVE LIFE SCIENCES LTD. By: /s/ Paul B. Bolno, M.D. Paul B. Bolno, M.D. President and Chief Executive Officer Date: June 25, 2024